Arcturus Therapeutics has appointed Robert Baltera and Stuart Collinson to its board of directors.
Baltera previously served as CEO of Amira Pharmaceuticals, which was acquired by Bristol-Myers Squibb. Before that, he held various roles at Amgen. He is currently on the board of Organovo Holdings, Xencor, Panmira Pharmaceuticals, and San Diego Venture Group.
Collinson is a partner at investment firm Forward Ventures and is executive chairman of Tioga Pharmaceuticals. He previously was chairman, CEO, and president of Aurora Biosciences, which was acquired by Vertex. He has also held different senior management positions at GlaxoWellcome (now GlaxoSmithKline) and Baxter International.
Tauriga Sciences has appointed Robert Millman to its business advisory board.
Millman is currently a managing director at MPM Capital and previously was chief intellectual property counsel for Alnylam Pharmaceuticals.